Evidence map›Paper›PMID 23291607›Full record

Trial reportMechanisms of ageing and development

Compensatory increase in USP14 activity accompanies impaired proteasomal proteolysis during aging.

Subramaniam Ponnappan, Michela Palmieri, Dennis H Sullivan, Usha Ponnappan

Abstract readClinical Trial
In one paragraph

Trial report in Mechanisms of ageing and development. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Subramaniam PonnappanDepartment of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. sponnappan@uams.edu
Michela Palmieri
Dennis H Sullivan
Usha Ponnappan
University of Arkansas for Medical Sciences · USCentral Arkansas Veterans Healthcare System · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029884 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI LOWERY, CURTIS L · 2009 to 2011
$11.4M
Modulation of Immune senescence by induction of Ubiquitin-Proteasome systemsR01AG030599 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI PONNAPPAN, USHA · 2008 to 2012
$1.3M
Regulatory Ubiquitination in Immune senescenceR01AG025220 · NIA · UNIV OF ARKANSAS FOR MED SCIS · PI PONNAPPAN, USHA · 2007 to 2011
$1.2M
NCRR NIH HHS UL1 RR029884NCRR NIH HHS UL1RR029884NIA NIH HHS AG025220NIA NIH HHS R01 AG025220NIA NIH HHS R01 AG030599
6 · The paper itself

Abstract

The deubiquitinating enzyme, USP14, found in association with the proteasome is essential in mediating ubiquitin trimming and in ensuring ubiquitin-homeostasis. As aging is accompanied by a significant decline in proteasomal proteolysis in primary human T lymphocytes, we evaluated the contributory role of USP14 in this decline. Our studies for the first time demonstrate that enzymatic activity of proteasome-associated USP14 is significantly higher in T cells obtained from elderly donors. Additionally, such an increase in USP14 activity could be mimicked by chemically inhibiting the proteasome, using lactacystin. Thus, USP14 activity appears to be reciprocally regulated by the catalytic function of the 26S proteasome. To determine whether the inhibition of USP14 activity counter regulates proteasomal proteolysis, T cells pretreated with a small molecule inhibitor of USP14, IU1, were activated and assessed for IκBα degradation as a measure of proteasomal proteolysis. While T cells obtained from young donors demonstrated increased degradation of IκBα, those from the elderly remained unaffected by IU1 pretreatment. Taken together, these results demonstrate that the decrease in proteolysis of proteasomal substrates during aging is independent of the increased USP14 activity and that the reciprocal regulation of USP14 and proteasomal catalytic activity may be necessary to maintain cellular ubiquitin homeostasis.

Indexed as

ProteolysisAcetylcysteineAdultAgedAged, 80 and overAgingCysteine Proteinase InhibitorsFemaleHemostasisHumansI-kappa B ProteinsMaleNF-KappaB Inhibitor alphaProteasome Endopeptidase ComplexT-LymphocytesUbiquitinAcetylcysteineATP dependent 26S proteaseCysteine Proteinase InhibitorsI-kappa B ProteinslactacystinNF-KappaB Inhibitor alphaNFKBIA protein, humanProteasome Endopeptidase ComplexUbiquitinUbiquitin ThiolesteraseUSP14 protein, human

Identifiers

PMID23291607
PMCPMC3558606
OpenAlexW2062413299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.